GORE ACUSEAL VASCULAR GRAFT ECH460045A

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a company representative report with the FDA on 2020-01-22 for GORE ACUSEAL VASCULAR GRAFT ECH460045A manufactured by W.l. Gore & Associates.

Event Text Entries

[187880596] Review of the manufacturing records verified that the lot met release requirements. The device was not returned. Consequently, a direct product analysis was not possible. All information has been placed on file for use in tracking and trending.
Patient Sequence No: 1, Text Type: N, H10


[187880597] The following was reported to gore: the patient received a fistula for av access at the university hospital of (b)(6) and is sent home to (b)(6) for dialysis at fresenius kidney care. After approximately 2 weeks of dialysis with the fistula, the patient returns to university hospital of (b)(6), as the fistula has become non-functional (unable to be used for dialysis). The fistula is abandoned and the surgeon who created the fistula, implants a gore? Acuseal vascular graft on (b)(6) 2020 in the upper arm. The patient returns to hazard, kentucky for dialysis. Patient presented at fresenius kidney care ((b)(6)) for dialysis (b)(6) 2020 (2 days post implant). Two 17 gauge dialysis needles are used to access inflow and outflow of the acuseal graft and the dialysis machine is adjusted to 100ml per minute for the initial time period on dialysis. During the dialysis session the patient complained about arm pain and swelling/hematoma was observed. The patient was sent to (b)(6) medical center er with the two dialysis needles still in the arm. Fasciotomy is performed to control bleeding and to treat compartment syndrome. The er surgeon reported there were no visible problems associated with the gore? Acuseal vascular graft and both venous and arterial anastomoses appeared intact. The two dialysis needle cannulation holes were observed on the anterior aspect of the graft. Er surgeon placed a stay-suture on one of the cannulation needle holes of the acuseal graft. On (b)(6) 2020 the later patient returns to university hospital of (b)(6) where a fistula gram is performed by the implanting surgeon. During the procedure the surgeon observed that the gore? Acuseal vascular graft was functioning as intended, no outflow stenosis was observed, and that a suture had been placed on one of the needle holes of the graft. The patient is currently recovering and dialyzing through a catheter until the surgeon decides when to initiate cannulation through the acuseal graft.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number2017233-2020-00048
MDR Report Key9618623
Report SourceCOMPANY REPRESENTATIVE
Date Received2020-01-22
Date of Report2020-01-07
Date of Event2020-01-04
Device Manufacturer Date2019-10-11
Date Added to Maude2020-01-22
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Reporter OccupationRISK MANAGER
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactCRAIG BEARCHELL
Manufacturer Street1500 N. 4TH STREET
Manufacturer CityAZ
Manufacturer Phone9285263030
Manufacturer G1MEDICAL WEST B/P
Manufacturer Street1505 N. FOURTH STREET
Manufacturer CityFLAGSTAFF AZ 86004
Manufacturer CountryUS
Manufacturer Postal Code86004
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameGORE ACUSEAL VASCULAR GRAFT
Generic NamePROSTHESIS, VASCULAR GRAFT
Product CodeDSY
Date Received2020-01-22
Model NumberECH460045A
Catalog NumberECH460045A
Lot Number6535184PP002
OperatorHEALTH PROFESSIONAL
Device AvailabilityN
Device Eval'ed by MfgrR
Device Sequence No1
Device Event Key0
ManufacturerW.L. GORE & ASSOCIATES
Manufacturer AddressFLAGSTAFF AZ


Patients

Patient NumberTreatmentOutcomeDate
101. Required No Informationntervention 2020-01-22

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.